{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:40:10Z","timestamp":1749940810588,"version":"3.41.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>Drug combinations are being studied as potential therapies to increase the efficacy or improve the safety profile of weight loss medications. This study was designed to determine the anorectic interaction and safety profile of 5-hydroxytryptophan (5-HTP)\/carbidopa\u2009+\u2009diethylpropion and 5-HTP\/carbidopa\u2009+\u2009phentermine combinations in rats. The anorectic effect of individual drugs or in combination was evaluated by the sweetened milk test. Isobologram and interaction index were employed to determine the anorectic interaction between 5-HTP\/carbidopa and diethylpropion or phentermine. Plasma serotonin (5-HT) was measured by ELISA. Safety of repeated doses of both combinations in rats was evaluated using the tail sphygmomanometer, cardiac ultrasound, hematic biometry and blood chemistry. A single oral 5-HTP, diethylpropion or phentermine dose increased the anorectic effect, in a dose-dependent fashion, in 12\u2009h-fasted rats. A dose of carbidopa at 30 mg\/kg reduced the 5-HTP-induced plasmatic serotonin concentration and augmented the 5-HTP-induced anorectic effect. Isobologram and interaction index indicated a potentiation interaction between 5-HTP\/30 mg\/kg carbidopa\u2009+\u2009diethylpropion and 5-HTP\/30 mg\/kg carbidopa\u2009+\u2009phentermine. Chronic administration of experimental ED<jats:sub>40<\/jats:sub> of 5-HTP\/30 mg\/kg carbidopa\u2009+\u2009phentermine, but not 5-HTP\/30 mg\/kg carbidopa\u2009+\u2009diethylpropion, increased the mitral valve leaflets area. Moreover, there were no other significant changes in cardiovascular, hematic or blood parameters. Both combinations induced around 20% body weight loss after 3\u2009months of oral administration. Results suggest that 5-HTP\/30 mg\/kg carbidopa potentiates the anorectic effect of diethylpropion and phentermine with an acceptable safety profile, but further clinical studies are necessary to establish their therapeutic potential in the obesity treatment.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000625","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T12:09:06Z","timestamp":1614859746000},"page":"368-381","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Anorectic interaction and safety of 5-hydroxytryptophan\/carbidopa plus phentermine or diethylpropion in rat"],"prefix":"10.1097","volume":"32","author":[{"given":"Ernesto","family":"Lim\u00f3n-Bernal","sequence":"first","affiliation":[{"name":"Secci\u00f3n de Estudios de Posgrado e Investigaci\u00f3n, Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 E.","family":"Roa-Coria","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Estudios de Posgrado e Investigaci\u00f3n, Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Z\u00fa\u00f1iga-Romero","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Estudios de Posgrado e Investigaci\u00f3n, Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Huerta-Cruz","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n en Farmacolog\u00eda, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosio Villegas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma R.C.","family":"Ru\u00edz-Velasco","sequence":"additional","affiliation":[{"name":"Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad Universitaria, Coyoac\u00e1n, Ciudad de M\u00e9xico, Mexico."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Flores-Murrieta","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Estudios de Posgrado e Investigaci\u00f3n, Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional"},{"name":"Unidad de Investigaci\u00f3n en Farmacolog\u00eda, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosio Villegas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleazar","family":"Lara-Padilla","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Estudios de Posgrado e Investigaci\u00f3n, Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan G.","family":"Reyes-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Estudios de Posgrado e Investigaci\u00f3n, Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor I.","family":"Rocha-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Secci\u00f3n de Estudios de Posgrado e Investigaci\u00f3n, Escuela Superior de Medicina, Instituto Polit\u00e9cnico Nacional"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/syn.20126","article-title":"Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis.","volume":"56","author":"Alexander","year":"2005","journal-title":"Synapse"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0074-7742(09)88009-4","article-title":"Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion.","volume":"88","author":"Arias","year":"2009","journal-title":"Int Rev Neurobiol"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.ijo.0800589","article-title":"Effects of phentermine on striatal dopamine and serotonin release in conscious rats: in vivo microdialysis study.","volume":"22","author":"Balcioglu","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0024-3205(86)90311-5","article-title":"Further evidence of the inhibitory role of perifornical hypothalamic beta-adrenergic receptors in the feeding behaviour of hungry rats.","volume":"38","author":"Bendotti","year":"1986","journal-title":"Life Sci"},{"key":"R5-20250614","first-page":"271","article-title":"5-Hydroxytryptophan: a clinically-effective serotonin precursor.","volume":"3","author":"Birdsall","year":"1998","journal-title":"Altern Med Rev"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0091-3057(79)90120-5","article-title":"Serotonergic influences on food intake: effect of 5-hydroxytryptophan on parameters of feeding behaviour in deprived and free-feeding rats.","volume":"11","author":"Blundell","year":"1979","journal-title":"Pharmacol Biochem Behav"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.2042-7158.1975.tb09374.x","article-title":"The effect of 5-hydroxytryptophan on food intake and on the anorexic action of amphetamine and fenfluramine.","volume":"27","author":"Blundell","year":"1975","journal-title":"J Pharm Pharmacol"},{"key":"R8-20250614","first-page":"3","article-title":"The roles of brain noradrenaline and dopamine in the anorectic activity of diethylpropion in rats: a comparison with d-amphetamine.","volume":"26","author":"Borsini","year":"1979","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/978-1-4684-5952-4_73","article-title":"Effects of 5-hydroxytryptophan on eating behavior and adherence to dietary prescriptions in obese adult subjects.","volume":"294","author":"Cangiano","year":"1991","journal-title":"Adv Exp Med Biol"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/ajcn\/56.5.863","article-title":"Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan.","volume":"56","author":"Cangiano","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF01578751","article-title":"The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects.","volume":"76","author":"Ceci","year":"1989","journal-title":"J Neural Transm"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2337\/dc15-1081","article-title":"Advances in the science, treatment, and prevention of the disease of obesity: reflections from a diabetes care editors\u2019 expert forum.","volume":"38","author":"Cefalu","year":"2015","journal-title":"Diabetes Care"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ddr.21434","article-title":"Anorectic efficacy and safety of the diethylpropion-topiramate combination in rats.","volume":"79","author":"Cort\u00e9s-Moreno","year":"2018","journal-title":"Drug Dev Res"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nm.3766","article-title":"Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis.","volume":"21","author":"Crane","year":"2015","journal-title":"Nat Med"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/ilar.43.4.207","article-title":"Sample size determination.","volume":"43","author":"Dell","year":"2002","journal-title":"ILAR J"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00428323","article-title":"The effect of propranolol phentolamine and pimozide on drug-induced anorexia in the mouse.","volume":"66","author":"Dobrzanski","year":"1979","journal-title":"Psychopharmacology (Berl)"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12012-009-9046-2","article-title":"Dose dependency and reversibility of serotonin-induced valvular heart disease in rats.","volume":"9","author":"Droogmans","year":"2009","journal-title":"Cardiovasc Toxicol"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.clinthera.2019.06.005","article-title":"Short-term evidence in adults of anorexigenic drugs acting in the central nervous system: a meta-analysis.","volume":"41","author":"Farah","year":"2019","journal-title":"Clin Ther"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0091-3057(88)90173-6","article-title":"Interaction between opioid agonists or naloxone and 5-HTP on feeding behavior in food-deprived rats.","volume":"29","author":"Fernandez-Tome","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1210\/jc.2011-1256","article-title":"A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial.","volume":"96","author":"Fidler","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF00310632","article-title":"Dissociation of the anorectic actions of 5-HTP and fenfluramine.","volume":"89","author":"Fletcher","year":"1986","journal-title":"Psychopharmacology (Berl)"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2174\/1573399815666191113125247","article-title":"Meta-analysis and approach of the real impact of anorexigenic drugs in the obesity in humans: the last five years of the randomized studies.","volume":"16","author":"Garcia Ramirez","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.","volume":"95","author":"Garvey","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00004714-200204000-00012","article-title":"Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers.","volume":"22","author":"Gijsman","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ijo.2015.59","article-title":"Physiological adaptations to weight loss and factors favouring weight regain.","volume":"39","author":"Greenway","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/01.CIR.0000159356.42064.48","article-title":"Long-term serotonin administration induces heart valve disease in rats.","volume":"111","author":"Gustafsson","year":"2005","journal-title":"Circulation"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/oby.2009.69","article-title":"How physician obesity specialists use drugs to treat obesity.","volume":"17","author":"Hendricks","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"e00594","DOI":"10.1002\/brb3.594","article-title":"Preliminary fMRI findings concerning the influence of 5-HTP on food selection.","volume":"7","author":"Ioannou","year":"2016","journal-title":"Brain Behav"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00004872-198904000-00011","article-title":"5-Hydroxytryptophan and carbidopa in spontaneously hypertensive rats.","volume":"7","author":"Itskovitz","year":"1989","journal-title":"J Hypertens"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1152\/jn.00012.2015","article-title":"D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell.","volume":"114","author":"Kalyanasundar","year":"2015","journal-title":"J Neurophysiol"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4082\/kjfm.2013.34.5.298","article-title":"Postmarketing surveillance study of the efficacy and safety of phentermine in patients with obesity.","volume":"34","author":"Kim","year":"2013","journal-title":"Korean J Fam Med"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3945\/an.112.002063","article-title":"Global gender disparities in obesity: a review.","volume":"3","author":"Kanter","year":"2012","journal-title":"Adv Nutr"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/0024-3205(83)90008-5","article-title":"Anorectic drugs which stimulate thermogenesis.","volume":"33","author":"Lang","year":"1983","journal-title":"Life Sci"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7326\/0003-4819-142-7-200504050-00012","article-title":"Meta-analysis: pharmacologic treatment of obesity.","volume":"142","author":"Li","year":"2005","journal-title":"Ann Intern Med"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"317","DOI":"10.6061\/clinics\/2017(05)10","article-title":"Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients.","volume":"72","author":"Lucchetta","year":"2017","journal-title":"Clinics (Sao Paulo)"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1038\/ncomms7794","article-title":"Regulation of systemic energy homeostasis by serotonin in adipose tissues.","volume":"6","author":"Oh","year":"2015","journal-title":"Nat Commun"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3389\/fphar.2019.01327","article-title":"The triple combination phentermine plus 5-htp\/carbidopa leads to greater weight loss, with fewer psychomotor side effects than each drug alone.","volume":"10","author":"Perez","year":"2019","journal-title":"Front Pharmacol"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130050598","article-title":"Efficacy of administration of dexfenfluramine and phentermine, alone and in combination, on ingestive behavior and body weight in rats.","volume":"137","author":"Roth","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(99)00235-6","article-title":"Anorectic efficacy of the fenfluramine\/phentermine combination in rats: additivity or synergy?","volume":"373","author":"Roth","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/ijo.2008.91","article-title":"Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.","volume":"32","author":"Roth","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"key":"R42-20250614","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"key":"R43-20250614","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1196\/annals.1369.064","article-title":"Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs.","volume":"1074","author":"Rothman","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"R44-20250614","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/MJT.0b013e31818e30da","article-title":"Treatment of obesity with \u201ccombination\u201d pharmacotherapy.","volume":"17","author":"Rothman","year":"2010","journal-title":"Am J Ther"},{"key":"R45-20250614","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s002139900336","article-title":"Comparison of either norepinephrine-uptake inhibitors or phentermine combined with serotonergic agents on food intake in rats.","volume":"149","author":"Rowland","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"R46-20250614","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200011)38:2<167::AID-SYN8>3.0.CO;2-W","article-title":"Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats.","volume":"38","author":"Rowley","year":"2000","journal-title":"Synapse"},{"key":"R47-20250614","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7861\/clinmedicine.19-3-205","article-title":"Current treatments for obesity.","volume":"19","author":"Ruban","year":"2019","journal-title":"Clin Med (Lond)"},{"key":"R48-20250614","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0773.1993.tb01537.x","article-title":"Neurochemical mechanism of action of anorectic drugs.","volume":"73","author":"Samanin","year":"1993","journal-title":"Pharmacol Toxicol"},{"key":"R49-20250614","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7326\/0003-4819-142-7-200504050-00012","article-title":"Meta-analysis: pharmacologic treatment of obesity.","volume":"142","author":"Li","year":"2005","journal-title":"Ann Intern Med"},{"key":"R50-20250614","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0031-9384(89)90044-9","article-title":"Electrochemical analysis of hypothalamic serotonin metabolism accompanied by immobilization stress in rats.","volume":"46","author":"Shimizu","year":"1989","journal-title":"Physiol Behav"},{"key":"R51-20250614","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0269881107082025","article-title":"Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.","volume":"22","author":"Smarius","year":"2008","journal-title":"J Psychopharmacol"},{"key":"R52-20250614","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5414\/CP202135","article-title":"Six-month efficacy and safety of amfepramone in obese Mexican patients: a double-blinded, randomized, controlled trial.","volume":"53","author":"Soto-Molina","year":"2015","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R54-20250614","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3959(02)00041-6","article-title":"The interaction index: a measure of drug synergism.","volume":"98","author":"Tallarida","year":"2002","journal-title":"Pain"},{"key":"R55-20250614","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ijo.2013.120","article-title":"Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study.","volume":"37","author":"Wadden","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"R56-20250614","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0091-3057(77)90112-5","article-title":"A new anorexigen assay: stress-induced hyperphagia in rats.","volume":"6","author":"Wallach","year":"1977","journal-title":"Pharmacol Biochem Behav"},{"key":"R57-20250614","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/en.2009-1349","article-title":"Peripheral serotonin enhances lipid metabolism by accelerating bile acid turnover.","volume":"151","author":"Watanabe","year":"2010","journal-title":"Endocrinology"},{"key":"R58-20250614","doi-asserted-by":"crossref","first-page":"e0147143","DOI":"10.1371\/journal.pone.0147143","article-title":"Serotonin improves high fat diet induced obesity in mice.","volume":"11","author":"Watanabe","year":"2016","journal-title":"PLoS One"},{"key":"R59-20250614","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0165-1781(82)90074-9","article-title":"Kinetics of l-5-hydroxytryptophan in healthy subjects.","volume":"7","author":"Westenberg","year":"1982","journal-title":"Psychiatry Res"},{"key":"R60-20250614","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1248\/bpb.29.557","article-title":"Involvement of leptin in hypophagia induced by the serotonin precursor 5-hydroxytryptophan (5-HTP) in mice.","volume":"29","author":"Yamada","year":"2006","journal-title":"Biol Pharm Bull"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:04:46Z","timestamp":1749938686000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000625","relation":{},"ISSN":["0955-8810"],"issn-type":[{"type":"print","value":"0955-8810"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}